PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.\', \'School of Computing and Information, Pittsburgh, PA.\', \'Departments of Pathology, Bioengineering, and Computational and Systems Biology, Pittsburgh, PA.\', \'Departments of Pathology and Immunology, Pittsburgh, PA.\', \'Departments of Pathology, Critical Care Medicine, and Clinical and Translational Science, Pittsburgh, PA.\', \'Department of Pathology, University of Pittsburgh, Pittsburgh, PA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/ajcp/aqaa228
?:hasPublicationType
?:journal
  • American journal of clinical pathology
is ?:pmid of
?:pmid
?:pmid
  • 33155015
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.002
?:rankingScore_hIndex
  • 113
is ?:relation_isRelatedTo_publication of
?:title
  • Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all